Cobicistat : A case of mislabelled drug-drug interaction risk?

Burger, David M; Calmy, Alexandra; Marzolini, Catia

doi:10.1111/bcp.14262

Scientific article

Editorial

Open access

English

Cobicistat : A case of mislabelled drug-drug interaction risk?

ContributorsBurger, David M

; Calmy, Alexandra

; Marzolini, Catia

Published inBritish journal of clinical pharmacology, vol. 86, no. 5, p. 834-836

Publication date2020-05

First online date2020-03-06

Keywords

HIV/AIDS
Cytochrome P450
Drug interactions
Anti-HIV Agents / pharmacology
Cobicistat / pharmacology
Darunavir
Drug Interactions
Drug Labeling
HIV Infections / drug therapy
Humans
Pharmaceutical Preparations

Affiliation

Faculté de médecine / Section de médecine clinique / Département de médecine

Research group

Citation (ISO format)

BURGER, David M, CALMY, Alexandra, MARZOLINI, Catia. Cobicistat : A case of mislabelled drug-drug interaction risk? In: British journal of clinical pharmacology, 2020, vol. 86, n° 5, p. 834–836. doi: 10.1111/bcp.14262

Article (Published version)

CC BY-NC-4.0

Identifiers

PID : unige:173261
DOI : 10.1111/bcp.14262
PMID : 32144787
PMCID : PMC7163374

ISSN of the journal0306-5251

18views

4downloads

Creation02/23/2022 2:41:01 PM

First validation11/22/2023 2:52:15 PM

Update time11/22/2023 2:52:15 PM

Status update11/22/2023 2:52:15 PM

Last indexation05/06/2024 5:27:47 PM

Archive ouverte UNIGE

Cobicistat : A case of mislabelled drug-drug interaction risk?

Technical informations